Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Intarcia Therapeutics (United States)
InstitutionResearch output, impact & collaborations
Intarcia Therapeutics (United States) is a research organisation in Boston, US. OpenAlex records 229 works and 55,615 citations for it. 276 researchers list it as their most recent affiliation.
229
Works
55,615
Citations
276
Researchers
48
Avg h-index
How has Intarcia Therapeutics (United States)'s publication output changed over time?
ScholarIQpublication output · 2009–2011
Output grew100% over the shown period — from 1 works in 2009 to 2 in 2011.
1
2
20092011
What are the most-cited papers on Intarcia Therapeutics (United States)?
ScholarIQmost cited works
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Nicolas Stransky, Ann Marie Egloff, Aaron D. Tward, Aleksandar D. Kostic, Kristian Cibulskis, Andrey Sivachenko, Gregory V. Kryukov, Michael S. Lawrence, Carrie Sougnez, Aaron McKenna, Erica Shefler, Alex H. Ramos, Petar Stojanov, Scott L. Carter, Douglas Voet, Maria L. Cortés, Daniel Auclair, Michael F. Berger, Gordon Saksena, Candace Guiducci, Robert C. Onofrio, Melissa Parkin, Marjorie Romkes, Joel L. Weissfeld, Raja R. Seethala, Lin Wang, Claudia Rangel‐Escareño, Juan Carlos Fernández-López, Alfredo Hidalgo‐Miranda, Jorge Meléndez-Zajgla, Wendy Winckler, Kristin Ardlie, Stacey Gabriel, Matthew Meyerson, Eric S. Lander, Gad Getz, Todd R. Golub, Levi A. Garraway, Jennifer R. Grandis
Science. 20112,556 CitationsOPEN ACCESS
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
Adam J. Bass, Hideo Watanabe, Craig H. Mermel, Soyoung Yu, Sven Perner, Roel G.W. Verhaak, So Young Kim, Leslie Wardwell, Pablo Tamayo, Irit Gat‐Viks, Alex H. Ramos, Michele Sue‐Ann Woo, Barbara A. Weir, Gad Getz, Rameen Beroukhim, Michael O'Kelly, Amit Dutt, Orit Rozenblatt–Rosen, Piotr Dziunycz, Justin Komisarof, Lucian R. Chirieac, Christopher J. Lafargue, Veit Scheble, Theresia Wilbertz, Changqing Ma, Shilpa Rao, Hiroshi Nakagawa, Douglas B. Stairs, Lin Lin, Thomas J. Giordano, Patrick Wagner, John D. Minna, Adi F. Gazdar, Chang‐Qi Zhu, Marcia S. Brose, Ivan Cecconello, Ulysses Ribeiro, Suely Kazue Nagahashi Marie, Olav Dahl, Ramesh A. Shivdasani, Ming‐Sound Tsao, Mark A. Rubin, Kwok‐Kin Wong, Aviv Regev, William C. Hahn, David G. Beer, Anil K. Rustgi, Matthew Meyerson
S137905309. 2009956 CitationsOPEN ACCESS
Mutations in the <i>DDR2</i> Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
Peter S. Hammerman, Martin L. Sos, Alex H. Ramos, Chunxiao Xu, Amit Dutt, Wenjun Zhou, Lear E. Brace, Brittany A. Woods, Wenchu Lin, Jianming Zhang, Xianming Deng, Sang Min Lim, Stefanie Heynck, Martin Peifer, Jeffrey R. Simard, Michael S. Lawrence, Robert C. Onofrio, Helga B. Salvesen, Danila Seidel, Thomas Zander, Johannes M. Heuckmann, Alex Soltermann, Holger Moch, Mirjam Koker, Frauke Leenders, Franziska Gabler, Silvia Querings, Sascha Ansén, Élisabeth Brambilla, Christian Brambilla, Philippe Lorimier, Odd Terje Brustugun, Åslaug Helland, Iver Petersen, Joachim H. Clement, Harry J.M. Groen, Wim Timens, Hannie Sietsma, Erich Stoelben, Jürgen Wolf, David G. Beer, Ming‐Sound Tsao, Megan Hanna, Charlie Hatton, Michael J. Eck, Pasi A. Jänne, Bruce E. Johnson, Wendy Winckler, Heidi Greulich, Adam J. Bass, Jeonghee Cho, Daniel Rauh, Nathanael S. Gray, Kwok‐Kin Wong, Eric B. Haura, Roman K. Thomas, Matthew Meyerson
Cancer Discovery. 2011473 CitationsOPEN ACCESS
How much of the research on Intarcia Therapeutics (United States) is open access?
ScholarIQopen access share
100%OPEN ACCESS
Gold
0%
Green
33%
Hybrid
0%
Bronze
67%
Closed
0%